In September, AbbVie, the US-based big pharma, established a China Development Team to speed development of AbbVie’s innovative drugs for the China market. The company considers China an important market, and China’s recent drug approval reforms will facilitate the introduction of novel drugs in China, AbbVie says. In 2013, the company set up its China headquarters in Shanghai. AbbVie’s upbeat assessment of China is a significant endorsement of the country’s porposed changes to its drug regulatory system.
Help employers find you! Check out all the jobs and post your resume.
